VC Wants Growth at All Costs. Insurance Wants Safe and Steady. Those Two Instincts Are Structurally Opposed.

Tiffine Wang’s path into venture is genuinely unusual for the category. She started in biochemistry research — literally pipetting droplets of water in a lab, before that work was automated — decided she didn’t want to spend her career there, taught first grade for two years, then moved into workforce development as a caseworker helping people find jobs after layoffs or incarceration. What pushed her out of that work wasn’t burnout — it was scale. With roughly 65 people on her caseload at any time, she watched people cycle back into the same circumstances and told her boss she wanted bigger impact. That boss told her to leave.

That conversation led her into tech and venture, where she fell in love with a specific idea: scalability — building something once that could help far more people than any caseworker ever could reach directly. She built out mentoring programs at Alchemist Accelerator, helped run entrepreneurship training for the European Innovation Academy across Estonia, France, Portugal, Hong Kong, and China, then spent five years at Singtel doing both investment and tech-scouting work across Southeast Asia, before joining MS&AD Ventures roughly four years before this recording.

In Episode 100 of InsurTechTalk — recorded at ITC DIA Europe in Barcelona — Tiffine and I covered why the fundamental incentive structures of venture capital and insurance pull in opposite directions, why narrowly-focused MGAs are struggling to raise capital in the current market, and what she tells founders about being genuinely ready to work with a large strategic corporate partner.

About Tiffine Wang

Tiffine Wang is a Partner at MS&AD Ventures, the venture arm of MS&AD Holdings — a large Japanese insurance conglomerate (Mitsui Sumitomo and Aioi Nissay Dowa). MS&AD Ventures manages roughly $300 million, investing from pre-seed through Series A (with select later-stage exceptions), and is currently deploying its fourth fund at a pace of roughly 15-20 investments per year, with typical check sizes of $1-3 million. The team of roughly 10 people splits its work between direct early-stage investing and technology scouting/partnership-building on behalf of MS&AD’s parent businesses, which operate in around 50 countries (Japan itself is handled by a separate internal MS&AD entity). Before MS&AD, Tiffine spent five years at Singtel doing similar dual-function investment and tech-scouting work across Southeast Asia and Australia.

Coming Into Insurance With No Insurance Background

Tiffine’s honest self-assessment: she was genuinely new to insurance when she joined MS&AD roughly three and a half to four years before this recording — with an amusing personal footnote that she’d briefly tried selling Aflac as a young person and failed at it, finding it genuinely hard as an optimist to lead every sales conversation with “here’s what can go wrong.”

Her framing of what drew her to the space once she understood it better: insurance, at its core, exists to protect families and society, and that protection is what allows people and businesses to take on higher, more productive risk than they otherwise could. What surprised her most on joining: how far behind the technology curve the industry actually was. Cloud adoption, API integration — conversations that felt basic elsewhere in tech — were still emerging when she joined. Even more strikingly, she found that MS&AD, like much of the incumbent industry, had essentially no in-house engineering talent; most technical work was outsourced.

The Structural Conflict Between VC and Insurance

This was the sharpest and most useful insight in the conversation, and it directly explains a lot of the insurtech funding struggles of the period.

Tiffine’s framing: insurance companies, by design and regulatory necessity, optimize for safe, steady, predictable growth — rapid growth in an insurance book is actually viewed as a red flag, not an achievement, because it usually signals underpriced or poorly underwritten risk. Venture capital wants the opposite: fast growth, high margins, scale at almost any near-term cost. Those two instincts are fundamentally, structurally in tension when applied to the same company.

Her practical resolution: the MGAs and insurtechs MS&AD has actually found genuinely venture-backable tend to bundle an insurance component with other genuine software or platform value — not purely an MGA underwriting a single line, but a company doing meaningful additional software work alongside the insurance piece, producing a business model healthy enough to satisfy venture return expectations without violating the safe-growth logic that makes an insurance book actually sound.

Why Narrowly-Focused MGAs Are Struggling to Raise

Tiffine was direct about the state of the fundraising market at the time of recording: a narrowly focused MGA — even one that genuinely hit the metrics it promised back in 2021 — is often still failing to raise, because the bar across the entire category has shifted upward, and many of these companies were priced too high relative to where the market now sits.

Her practical advice for founders in that position: consider a repricing down round if the fundamentals are genuinely sound, or seriously consider an acqui-hire or M&A exit if a clean sale is achievable, rather than staying trapped trying to grow into a valuation set during a very different funding environment. Her broader framing, delivered without any stigma attached: strong entrepreneurs often build multiple companies across a career — exiting cleanly and starting fresh is a legitimate, common path, not a failure state.

When to Actually Talk to an Investment Banker

Asked directly about the right moment for a struggling founder to engage an investment banker, Tiffine’s answer was blunt and specific: roughly a year of runway remaining is the point where a founder still has genuine leverage in a sale or fundraising process. Below three to six months of runway, control has effectively already been lost — the priority at that point shifts entirely to reaching cash-flow positive: cutting staff, cutting burn, serving existing customers, and stabilizing, because buyers and bankers alike understand the landscape and will price accordingly once a company is visibly out of leverage.

What Genuine Partnership Readiness Looks Like

Tiffine’s advice to founders considering a corporate venture partnership like MS&AD’s carries a specific warning: large corporates have all the time in the world; startups do not. A corporate can meet with a promising startup for six months, express genuine interest, and then push the decision to next fiscal year without meaningfully damaging themselves — while a startup with 12-18 months of runway that spends that time in unproductive corporate meetings instead of closing revenue can die from the delay alone, regardless of how promising those meetings felt.

Her specific cultural insight, drawing on her cross-cultural work across Japanese, Israeli, and other markets: what looks like inefficiency from an outside (particularly American) perspective is often deeply core to a culture’s actual value system — her example being the Japanese emphasis on doing something thoroughly and correctly, which a pure cost-cutting pitch can inadvertently undervalue or even offend, if a founder doesn’t understand what’s actually being optimized for on the other side of the table.

Her practical recommendation: founders with prior international business experience tend to succeed faster with corporates like MS&AD, precisely because they already understand how genuinely difficult and slow cross-regional and cross-cultural sales actually are — and set their own expectations (and runway planning) accordingly.

Corporate Innovation Budgets vs. Insurtech Survival Pressure

Tiffine offered a clear-eyed comparison of why insurtechs often out-execute large incumbent innovation teams on speed, despite far smaller budgets. An insurtech given a metric to hit will move fast because failing to hit it means the company dies. A large corporate team given a $2 million POC budget faces a fundamentally different incentive: it’s easy to simply push the decision to next quarter, repeatedly, with genuinely lower personal or organizational consequence — corporates are also, reasonably, more risk-averse given that they’re managing millions of existing policies and real regulatory exposure that a small insurtech simply doesn’t carry yet.

What MS&AD Actually Invests In

MS&AD Ventures generally avoids pure “enablement” technology vendors and SaaS-only providers, though the firm engages with them actively as partnership-scouting targets for MS&AD’s parent operating businesses without necessarily needing to invest directly. Tiffine’s framing: as a venture fund, the job is ultimately to return capital, which means seeking companies capable of genuinely large outcomes — and MS&AD would rather introduce a strong enabling technology to its parent company’s global operating businesses (which can adopt it without MS&AD needing equity exposure) than force an investment purely to justify a partnership relationship.

The Bigger Opportunity: A Growing Market, Not Just a Zero-Sum Fight

Tiffine pushed back on the “insurtechs will disintermediate incumbents” framing that’s dominated a lot of industry discourse. Her view: insurtechs generally don’t actually want to become full insurance companies — the margin profile and regulatory burden of running an insurance company is genuinely worse than running a technology company. As insurtechs mature, she expects the market to expand rather than simply redistribute — new, genuinely novel products become buildable specifically because of tech-native infrastructure, meaning the addressable opportunity grows rather than incumbents and insurtechs purely fighting over a fixed pie.

Her closing framing on the industry’s actual purpose, delivered with real conviction: most people don’t want to spend their time comparing ten policy options — they want to live their lives, protect their families and businesses, and know things will be handled when something goes wrong. Her challenge to the industry: declining to underwrite a bad risk doesn’t actually solve the underlying problem — a flood will still hit an underinsured community regardless of who wrote (or declined) the policy. The higher-value opportunity for insurance professionals, in her view, is proactive risk mitigation support — not just pricing and issuing policies, but genuinely helping communities and businesses become more resilient, rather than purely cherry-picking good risk and walking away from bad risk.

Advice: Listen to Yourself, and Don’t Play Small

Asked for closing advice, Tiffine offered two points. First: when genuinely lost or uncertain about a decision, deeply listening to yourself tends to surface the guidance actually needed — a reminder that self-trust, not just external advice, matters in founder and career decision-making. Second, and more pointed: build things that genuinely matter at scale — her explicit framing, “you don’t win by playing small” — encouraging entrepreneurs and insurance professionals alike to choose problems ambitious enough to genuinely help transform the world, not just problems safe enough to be comfortable pursuing.

Key Takeaways

• Venture capital’s growth-at-all-costs instinct and insurance’s safe-and-steady growth instinct are structurally opposed — the insurtechs MS&AD actually finds venture-backable tend to bundle genuine software value alongside the insurance component, not rely on insurance economics alone
• Narrowly focused MGAs that hit their 2021-era targets are still struggling to raise, because the market’s overall bar and pricing expectations have shifted — repricing or a clean M&A exit are often more realistic paths than continuing to chase a stale valuation
• Roughly a year of runway is the real threshold for engaging an investment banker with genuine leverage; below three to six months, the priority shifts entirely to reaching cash-flow positive
• Large corporate partners genuinely have unlimited time relative to a startup’s runway — founders need to structure partnership timelines and expectations accordingly, or risk running out of cash mid-negotiation
• Cross-cultural fluency is a genuine, underrated skill in international corporate partnerships — what looks like inefficiency from one culture’s perspective often reflects a genuinely different, deeply-held value system on the other side
• Insurtech maturity is expected to expand the overall addressable market rather than simply redistribute share from incumbents, because tech-native infrastructure enables genuinely new products that weren’t previously buildable at all
• The higher-value opportunity in insurance is proactive risk mitigation support for communities and businesses, not just accurate pricing and selective underwriting of already-good risk